Overview

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to investigate the drug interaction between Gemigliptin and Irbesartan by comparing pharmacokinetics of Gemigliptin and Irbesartan administered concomitantly and each alone in healthy male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

LG Life Sciences

Treatments:

Irbesartan